Lenalidomide Every Other Day for Myeloma Patients with Kidney Concerns?
Changing Careers in Midst of Myeloma…
Neutropenia in Multiple Myeloma and What You Need to Know
Baltimore Round Table - March 28, 2018
How Do I Exercise with Myeloma If I Am Elderly or Frail?
New Drug Targeting WT1 Found to Be Effective as Post-Transplant Myeloma Therapy for High-Risk Patients
Clinical Trial: Four Drug Induction Before Transplant Using Monoclonal Antibody for Newly Diagnosed Myeloma
Patient Power: Is Sugar Part of a Myeloma-Friendly Diet?
Armored CAR-T Cells
NAM-Natural Killer Cells with Elotuzumab by Viktoria Bachanova, MD, PhD, University of Minnesota
Dr. Bachanova shares why elotuzumab is used over daratumumab.
St. Louis Round Table - March 10th, 2018
Clinical Trial: Seattle Genetics’ SGN-CD48A Phase I Study for Patients with Relapsed/Refractory Myeloma
Spotlight on Myeloma: Multiple Myeloma Awareness Month
What is CAR-T Cell Therapy? 9 Things To Know
Long-Term Follow-Up of MGUS Patients
Managing Bone Disease With Multiple Myeloma
Clinical Trial: The MASTER Trial
Allogeneic Transplant and Precursor Myeloma Cells with William Matsui, MD, Johns Hopkins
Dr. William Matsui shares his experience with allo transplant for all patients, regardless of their age.
Flu Season Tips for Cancer Patients
Immune System Status May Be Why Myeloma Incidence Increases With Age
Dr. Martin Kaiser on Myeloma Treatment in the UK and the Study of Myeloma Genomics
Martin Kaiser discusses myeloma care in the United Kingdom and how the aggregation of genomic data from over 4,000 myeloma patients has helped advance research.
Blood Glucose, MGUS, Metformin and Myeloma: Part 2
New Test for Daratumumab (Darzalex) Patients Helps With M-Protein Accuracy
Family Genetic Mutations Linked to Multiple Myeloma Risk
